Access the full text.
Sign up today, get DeepDyve free for 14 days.
(2001)
Guiseppi-Elie A (2001) New developments in microarray
T. Yabe, M. Chat, E. Malherbe, P. Vidal (1992)
Effects of Ginkgo biloba extract (EGb 761) on the guinea pig vestibular systemPharmacology Biochemistry and Behavior, 42
S. Gandy, G. Caporaso, J. Buxbaum, B. Frangione, P. Greengard (1994)
APP processing, A beta-amyloidogenesis, and the pathogenesis of Alzheimer's disease.Neurobiology of aging, 15 2
Defeudis Fv, K. Drieu (2000)
Ginkgo biloba extract (EGb 761) and CNS functions: basic studies and clinical applications.Current drug targets, 1 1
J. Rapin, Ioanis Lamproglou, K. Drieu, F. Defeudis (1994)
Demonstration of the "anti-stress" activity of an extract of Ginkgo biloba (EGb 761) using a discrimination learning task.General pharmacology, 25 5
E. Ernst (2002)
The Risk–Benefit Profile of Commonly Used Herbal TherapiesAnnals of Internal Medicine, 137
Y. Ni, Baolu Zhao, J. Hou, W. Xin (1996)
Preventive effect of Ginkgo biloba extract on apoptosis in rat cerebellar neuronal cells induced by hydroxyl radicalsNeuroscience Letters, 214
S. Bastianetto, C. Ramassamy, S. Doré, Y. Christen, J. Poirier, R. Quirion (2000)
The Ginkgo biloba extract (EGb 761) protects hippocampal neurons against cell death induced by beta-amyloid.The European journal of neuroscience, 12 6
H. Zhuang, Sokhon Pin, Y. Christen, S. Doré (2002)
Induction of heme oxygenase 1 by Ginkgo biloba in neuronal cultures and potential implications in ischemia.Cellular and molecular biology, 48 6
Paul Smith, Karyn Maclennan, C. Darlington (1996)
The neuroprotective properties of the Ginkgo biloba leaf: a review of the possible relationship to platelet-activating factor (PAF).Journal of ethnopharmacology, 50 3
D. Blohm, A. Guiseppi-Elie (2001)
New developments in microarray technology.Current opinion in biotechnology, 12 1
C. Watanabe, S. Wolffram, P. Ader, G. Rimbach, L. Packer, J. Maguire, P. Schultz, K. Gohil (2001)
The in vivo neuromodulatory effects of the herbal medicine ginkgo bilobaProceedings of the National Academy of Sciences of the United States of America, 98
Junying Yuan, B. Yankner (2000)
Apoptosis in the nervous systemNature, 407
L. Squire (1992)
Memory and the hippocampus: a synthesis from findings with rats, monkeys, and humans.Psychological review, 99 2
Yuan Luo (2001)
Ginkgo biloba neuroprotection: Therapeutic implications in Alzheimer's disease.Journal of Alzheimer's disease : JAD, 3 4
Kenneth Neldner (2000)
Complementary and alternative medicine.Dermatologic clinics, 18 1
J. Smith, Yuan Luo (2003)
Elevation of oxidative free radicals in Alzheimer's disease models can be attenuated by Ginkgo biloba extract EGb 761.Journal of Alzheimer's disease : JAD, 5 4
(2002)
Comments on the paper by Paul R . Solomon et al . published in JAMA 21 August 2002
B. Meyer (1986)
[Multicenter randomized double-blind drug vs. placebo study of the treatment of tinnitus with Ginkgo biloba extract].Presse medicale, 15 31
(1993)
Primary therapy-resistant depressive instability in elderly patients with cerebral disorders: efficacy of a combination of Ginkgo biloba extract (EGb 761) with antidepressants
Zhixin Wu, J. Smith, V. Paramasivam, P. Butko, I. Khan, J. Cypser, Yuan Luo (2002)
Ginkgo biloba extract EGb 761 increases stress resistance and extends life span of Caenorhabditis elegans.Cellular and molecular biology, 48 6
R. Stackman, F. Eckenstein, B. Frei, Doris Kulhanek, Jessica Nowlin, J. Quinn (2003)
Prevention of age-related spatial memory deficits in a transgenic mouse model of Alzheimer's disease by chronic Ginkgo biloba treatmentExperimental Neurology, 184
M. Zimmermann, F. Colciaghi, F. Cattabeni, M. Luca (2002)
Ginkgo biloba extract: from molecular mechanisms to the treatment of Alzhelmer's disease.Cellular and molecular biology, 48 6
Yuan Luo, J. Smith, V. Paramasivam, Adam Burdick, K. Curry, Justin Buford, I. Khan, William Netzer, Huaxi Xu, P. Butko (2002)
Inhibition of amyloid-beta aggregation and caspase-3 activation by the Ginkgo biloba extract EGb761.Proceedings of the National Academy of Sciences of the United States of America, 99 19
E. Winter (1991)
Effects of an extract of Ginkgo biloba on learning and memory in micePharmacology Biochemistry and Behavior, 38
F. Defeudis (2002)
Effects of Ginkgo biloba extract (EGb 761) on gene expression: Possible relevance to neurological disorders and age‐associated cognitive impairmentDrug Development Research, 57
J. Sastre, A. Lloret, C. Borrás, J. Pereda, David García-Sala, M. Droy-lefaix, F. Pallardó, J. Viña (2002)
Ginkgo biloba extract EGb 761 protects against mitochondrial aging in the brain and in the liver.Cellular and molecular biology, 48 6
Gregory Juckett (2003)
Herbal MedicineFocus on Alternative and Complementary Therapies, 8
F. Defeudis (2002)
Bilobalide and neuroprotection.Pharmacological research, 46 6
E. Lien, S. Ren, H. Bui, Rubin Wang (1999)
Quantitative structure-activity relationship analysis of phenolic antioxidants.Free radical biology & medicine, 26 3-4
S. Pierre, I. Jamme, M. Droy-lefaix, A. Nouvelot, J. Maixent (1999)
Ginkgo biloba extract (EGb 761) protects Na,K-ATPase activity during cerebral ischemia in mice.Neuroreport, 10 1
J. Chen, H. Zeng, X. Chen, C. Su, C. Lai (2001)
Induction of heme oxygenase-1 by Ginkgo biloba extract but not its terpenoids partially mediated its protective effect against lysophosphatidylcholine-induced damage.Pharmacological research, 43 1
Jerrold Winter (1998)
The Effects of an Extract of Ginkgo biloba, EGb 761, on Cognitive Behavior and Longevity in the RatPhysiology & Behavior, 63
E. Ernst (2002)
The RiskBenefit Profile of Commonly Used Herbal Therapies: Ginkgo, St. John's Wort, Ginseng, Echinacea, Saw Palmetto, and KavaAnnals of Internal Medicine, 136
K. Gohil, L. Packer (2002)
Global gene expression analysis identifies cell and tissue specific actions of Ginkgo biloba extract, EGb 761.Cellular and molecular biology, 48 6
(2003)
From clinical observations to molecular biology
H. Amri, S. Ogwuegbu, N. Boujrad, K. Drieu, V. Papadopoulos (1996)
In vivo regulation of peripheral-type benzodiazepine receptor and glucocorticoid synthesis by Ginkgo biloba extract EGb 761 and isolated ginkgolides.Endocrinology, 137 12
B. Jacobs, W. Browner (2000)
Ginkgo biloba: a living fossil.The American journal of medicine, 108 4
H. Amri, K. Drieu, V. Papadopoulos (2002)
Use of ginkgolide B and a ginkgolide-activated response element to control gene transcription: example of the adrenocortical peripheral-type benzodiazepine receptor.Cellular and molecular biology, 48 6
M. Barkats, P. Venault, Y. Christen, C. Cohen-Salmon (1994)
Effect of long-term treatment with EGb 761 on age-dependent structural changes in the hippocampi of three inbred mouse strains.Life sciences, 56 4
A. Bilia (2002)
Ginkgo biloba L.Fitoterapia, 73 3
D. Eisenberg, Roger Davis, S. Ettner, Sarit Appel, Sonja Wilkey, M. Rompay, Ronald Kessler (1998)
Trends in alternative medicine use in the United States, 1990-1997: results of a follow-up national survey.JAMA, 280 18
H. Oberpichler, D. Sauer, C. Rossberg, H. Mennel, J. Krieglstein (1990)
PAF Antagonist Ginkgolide B Reduces Postischemic Neuronal Damage in Rat Brain HippocampusJournal of Cerebral Blood Flow & Metabolism, 10
J. Smith, Adam Burdick, P. Golik, I. Khan, D. Wallace, Yuan Luo (2002)
Anti-apoptotic properties of Ginkgo biloba extract EGb 761 in differentiated PC12 cells.Cellular and molecular biology, 48 6
K. Gohil, Ronald Moy, Sahar Farzin, J. Maguire, L. Packer (2000)
mRNA expression profile of a human cancer cell line in response to Ginkgo biloba extract: Induction of antioxidant response and the golgi systemFree Radical Research, 33
B. Oken, D. Storzbach, J. Kaye (1998)
The efficacy of Ginkgo biloba on cognitive function in Alzheimer disease.Archives of neurology, 55 11
M. Pardon, C. Joubert, F. Pérez-Diaz, Y. Christen, J. Launay, C. Cohen-Salmon (2000)
In vivo regulation of cerebral monoamine oxidase activity in senescent controls and chronically stressed mice by long-term treatment with Ginkgo biloba extrac3t (EGb 761)Mechanisms of Ageing and Development, 113
S. Gandy, G. Caporaso, J. Buxbaum, B. Frangione, P. Greengard (1994)
APP processing, Aβ-amyloidogenesis, and the pathogenesis of Alzheimer's diseaseNeurobiology of Aging, 15
D. Price, S. Sisodia (1998)
Mutant genes in familial Alzheimer's disease and transgenic models.Annual review of neuroscience, 21
K. Chandrasekaran, Z. Mehrabian, B. Spinnewyn, K. Drieu, G. Fiskum (2001)
Neuroprotective effects of bilobalide, a component of the Ginkgo biloba extract (EGb 761), in gerbil global brain ischemiaBrain Research, 922
Joseph Mix, W. Crews (2002)
A double‐blind, placebo‐controlled, randomized trial of Ginkgo biloba extract EGb 761® in a sample of cognitively intact older adults: neuropsychological findingsHuman Psychopharmacology: Clinical and Experimental, 17
C. Cohen-Salmon, P. Venault, P. Venault, Benoît Martin, M. Raffalli-Sebille, Martine Barkats, F. Clostre, Marie-Christine Pardon, Marie-Christine Pardon, Yves Christen, Georges Chapouthier, Georges Chapouthier (1997)
Effects of Ginkgo biloba extract (EGb 761) on learning and possible actions on agingJournal of Physiology-Paris, 91
S. Pietri, J. Seguin, P. D'arbigny, K. Drieu, M. Culcasi (1997)
Ginkgo biloba Extract (EGb 761) Pretreatment Limits Free Radical Oxidative Stress in Patients Undergoing Coronary Bypass SurgeryCardiovascular Drugs and Therapy, 11
C. Halsted (2003)
Dietary supplements and functional foods: 2 sides of a coin?The American journal of clinical nutrition, 77 4 Suppl
P. Solomon, F. Adams, A. Silver, J. Zimmer, R. Deveaux (2002)
Ginkgo for memory enhancement: a randomized controlled trial.JAMA, 288 7
Lenzi Pl, M. Katz, N. Berman, T. Itil, A. Freedman, A. Schatzberg (1997)
A placebo-controlled, double-blind, randomized trial of an extract of Ginkgo biloba for dementia. North American EGb Study Group.JAMA, 278 16
C. Ward, K. Redd, Beverly Williams, Jeffrey Caler, Yuan Luo, J. McCoy (2002)
Ginkgo biloba extract Cognitive enhancer or antistress bufferPharmacology Biochemistry and Behavior, 72
E. Tendi, F. Bosetti, S. Dasgupta, A. Stella, K. Drieu, S. Rapoport (2002)
Ginkgo biloba Extracts EGb 761 and Bilobalide Increase NADH Dehydrogenase mRNA Level and Mitochondrial Respiratory Control Ratio in PC12 CellsNeurochemical Research, 27
P. Bars, M. Katz, N. Berman, T. Itil, A. Freedman, A. Schatzberg (1997)
A Placebo-Controlled, Double-blind, Randomized Trial of an Extract of Ginkgo Biloba for DementiaJAMA, 278
S. Bastianetto, C. Ramassamy, S. Doré, Y. Christen, J. Poirier, R. Quirion (2000)
The ginkgo biloba extract (EGb 761) protects hippocampal neurons against cell death induced by β‐amyloidEuropean Journal of Neuroscience, 12
C. Soulié, A. Nicole, Y. Christen, I. Ceballos-Picot (2002)
The Ginkgo biloba extract EGb 761 increases viability of hnt human neurons in culture and affectsthe expression of genes implicated in the stress response.Cellular and molecular biology, 48 6
In the past decade, interest by the general public in the use of herbal dietary supplements has risen exponentially. As throughout history, individuals are now turning to the use of “natural” therapies for the prevention, treatment and cure of almost every ailment and aging malady imaginable... often without substantial proof of safety or efficacy. One of the most popular herbal supplements is Ginkgo biloba extract, taken for its perceived “memory enhancing” properties. Given the inordinate popularity, growing use, and substantial number of pharmaceutical products containing G. biloba, coupled with demands for product safety and “hard evidence,” science has followed this trend closely with an ever-expanding body of pharmacological and clinical data on such preparations. Claims that standardized G. biloba extract (EGb 761) can modulate the cellular environment of an organism under both physiological and stress conditions may be attributed to its multivalent or totipotent properties, and can now be substantiated by the availability of modern molecular techniques. As opposed to pharmacologically manufactured or synthetic drugs, which provide a single target for a single receptor as the mechanism of action, EGb 761 is able to up- or down-regulate signaling pathways, gene transcription, cellular metabolism, etc., and thus assist in the regulation of the general physiological status of the cell and/or organism in response to stressors posed by both intracellular and extracellular conditions. Presumably, this is one of the biggest advantages of using natural products for the prevention and treatment of infirmity, as well as the maintenance of health in an organism.
Applied Microbiology and Biotechnology – Springer Journals
Published: Jan 22, 2004
Read and print from thousands of top scholarly journals.
Already have an account? Log in
Bookmark this article. You can see your Bookmarks on your DeepDyve Library.
To save an article, log in first, or sign up for a DeepDyve account if you don’t already have one.
Copy and paste the desired citation format or use the link below to download a file formatted for EndNote
Access the full text.
Sign up today, get DeepDyve free for 14 days.
All DeepDyve websites use cookies to improve your online experience. They were placed on your computer when you launched this website. You can change your cookie settings through your browser.